We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Events

16 Nov 2026 - 19 Nov 2026
08 Dec 2026 - 10 Dec 2026

AI Risk Score Reveals Hidden Hypertension-Related Organ Damage

By HospiMedica International staff writers
Posted on 24 Jun 2026

Hypertension is a leading driver of cardiovascular, cerebrovascular, and renal morbidity, yet organ injury often remains clinically silent until late. More...

Reliance on blood pressure readings alone can miss patients who are progressing toward adverse events. This gap complicates risk stratification and timing of intervention in routine care. Researchers have now developed an artificial intelligence tool to map multiorgan injury patterns in people with high blood pressure.

HyperScore, an artificial intelligence (AI)-derived score led by the University of Oxford, estimates hypertension-related damage across multiple organs before a major cardiovascular event. The team also identified six distinct disease patterns, termed HyperTrajectories, that describe how organ systems are affected in different individuals. This framework is intended to capture heterogeneous pathways of disease that are not apparent from conventional clinic measurements alone.

To build HyperScore, investigators integrated hundreds of measures into a single model. Inputs reflected the heart, brain, kidneys, vasculature, lungs, liver, and metabolic profiles. The goal was to characterize the systemic burden of hypertension beyond a single blood pressure value.

The study applied machine learning to imaging and clinical data from more than 27,000 UK Biobank participants. External validation was performed in a further 5,500 participants from the U.S.-based Atherosclerosis Risk in Communities study. Individuals with higher HyperScores were more likely to experience future cardiovascular problems even when blood pressure alone did not separate risk. Brain changes detected on magnetic resonance imaging were among the strongest indicators associated with hypertension-related damage.

The work, published in Circulation on June 21, 2026, suggests potential use in earlier identification of people beginning to develop problems that could lead to stroke, heart failure, or kidney disease. The researchers emphasize that the approach is at an early stage and is not yet ready for routine clinical use. Further development and clinical studies are needed before adoption in care pathways.

“High blood pressure affects people very differently. Some individuals develop significant damage to the heart, brain or kidneys even when blood pressure is only mildly elevated, while others appear relatively protected despite longstanding hypertension. Our findings suggest that AI methods may help us move beyond treating hypertension based purely on blood pressure numbers, toward a more personalized understanding of how the disease affects the body,” said Dr. Mohanad Alkhodari, first author of the study and a current visiting researcher at the Radcliffe Department of Medicine's Clinical Cardiovascular Research Facility.

Related Links
University of Oxford's Radcliffe Department of Medicine


Gold Member
Blood Gas Analyzer
i-Check200
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Medical-Grade Display
HL2316SHTB
Wound Irrigation Solution
Prontosan®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: A view inside the custom virtual reality environment used in the study: a calm room with a teddy bear, soft colors and large windows looking out over the sea. (Image Credit: Walaa S. Abu Rukbah et al., Virginia Commonwealth University; CC-BY 4.0, https://creativecommons.org/licenses/by/4.0/)

Virtual Reality Program May Reduce Anxiety Before Pediatric Surgery

Presurgery anxiety affects an estimated 50% to 75% of children undergoing surgery and can complicate anesthesia induction, increase postoperative pain, and prolong recovery. Sedation is often used to manage... Read more

Medical Imaging

view channel
Image Credit: Adobe Stock

Lung Ultrasound Predicts Progression of Interstitial Lung Abnormalities in Rheumatoid Arthritis

Interstitial lung abnormalities are a pulmonary concern in patients with rheumatoid arthritis, requiring monitoring to detect disease progression. However, tracking these changes often involves repeated... Read more

Point of Care

view channel
Image: Fluorescence image of water-acetone mixture condensation. (Photo courtesy of Jingcheng Ma/Interfacial Thermofluids Laboratory)

New Breath Condensate Testing Approach Enhances Reliability for COPD Monitoring

Chronic obstructive pulmonary disease (COPD) is a progressive lung condition that can increasingly impair breathing over time. Diagnosis and monitoring may be burdensome because patients often require... Read more

Business

view channel
Image: Stryker has acquired ZuriMED, adding the FiberLocker System, a rotator cuff augmentation technology designed to strengthen repairs, to its Sports Medicine portfolio. (Photo courtesy of ZuriMED)

Stryker Completes Acquisition to Broaden Shoulder Surgery Offerings

Stryker (Portage, MI, USA) has completed its acquisition of ZuriMED (Zurich, Switzerland), a privately held developer of the FiberLocker System, expanding its Sports Medicine portfolio with a commercialized... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.